Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer

Akhil Chawla, George Molina, Linda M. Pak, Michael Rosenthal, Joseph D. Mancias, Thomas E. Clancy, Brian M. Wolpin, Jiping Wang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science